Comment[ArrayExpressAccession] E-GEOD-27984 MAGE-TAB Version 1.1 Public Release Date 2012-09-19 Investigation Title PPD stimulated PBMCs from tuberculosis patients, latent infectious individuals and healthy controls. Comment[Submitted Name] PPD stimulated PBMCs from tuberculosis patients, latent infectious individuals and healthy controls. Experiment Description Comprehensively compare the transcriptional difference in PPD stimulated PBMCs from individuals with different tuberculosis infectious status: tuberculosis patients, latent infectious individuals and healthy controls using the microarray analysis. Two-condition experiment, PBMCs vs. PPD-PBMCs. 12 individuals: 4 TB patients, 4 latent infectious individuals and 4 healthy controls. Term Source Name ArrayExpress EFO Term Source File http://www.ebi.ac.uk/arrayexpress/ http://www.ebi.ac.uk/efo/efo.owl Person Last Name Lu Lu Zhang Person First Name Chanyi Chanyi Wenhong Person Email yanzi.mutou@yahoo.com.cn Person Affiliation Fudan University Person Phone 86-15921587656 Person Address Fudan University, 220 Handan Rd, Shanghai, China Person Roles submitter Protocol Name P-GSE27984-1 P-GSE27984-6 P-GSE27984-3 P-GSE27984-8 P-GSE27984-7 P-GSE27984-2 P-GSE27984-4 P-GSE27984-5 Protocol Description ID_REF = VALUE = normalized log2 ratio (Cy3/Cy5) representing stimulated/unstimulated Each Slide was hybridized with 825ng Cy3-labeled cRNA and 825ng Cy-5 labeled cRNA using Gene Expression Hybridization Kit (Cat#5188-5242, Agilent technologies, Santa Clara, CA, US)in Hybridization Oven (Cat#G2545A, Agilent technologies, Santa Clara, CA, US), according to the manufacturer’s instructions. After 17 hours hybridization, slides were washed in staining dishes (Cat#121, Thermo Shandon, Waltham, MA, US)with Gene Expression Wash Buffer Kit (Cat#5188-5327, Agilent technologies, Santa Clara, CA, US), Stabilization and Drying Solution (Cat#5185-5979, Agilent technologies, Santa Clara, CA, US) followed the manufacturer’s instructions. PBMCs were cultured with AIM-V (Invitrogen Life Technologies, USA) containing 2 mM L-glutamine, 50 ug/ml streptomycin sulfate, and 10 ug/ml gentamicin. Raw data were normalized by Lowess(locally weighted scatter plot smoothing) algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US). Slides were scanned by Agilent Microarray Scanner (Cat#G2565BA, Agilent technologies, Santa Clara, CA, US) and Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US) with default settings. 10 ug/ml Mycobacterium tuberculosis purified protein derivative (PPD, Mycos Research LLC, Loveland, CO) treated or untreated for 4 hours before RNA extraction. Total RNA extracted using Trizol following manufacturer's instructions Total RNA were amplified and labeled by Low RNA Input Linear Amplification kit (Cat#5184-3523, Agilent technologies, Santa Clara, CA, US), 5-(3-aminoallyl)-UTP (Cat#AM8436, Ambion, Austin, TX, US), Cy3 NHS ester (Cat#PA13105, GE healthcare Biosciences, Pittsburgh, PA, US) ,Cy5 NHS ester (Cat#PA15100, GE healthcare Biosciences, Pittsburgh, PA, US)followed the manufacturer’s instructions. Labeled cRNA were purified by RNeasy mini kit (Cat#74106, QIAGEN, GmBH, Germany). Protocol Type bioassay_data_transformation hybridization grow feature_extraction image_aquisition specified_biomaterial_action nucleic_acid_extraction labeling Experimental Factor Name INFECTION STATUS Experimental Factor Type infection status Publication Title Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. Publication Author List Lu C, Wu J, Wang H, Wang S, Diao N, Wang F, Gao Y, Chen J, Shao L, Weng X, Zhang Y, Zhang W PubMed ID 21904626 Publication DOI 10.1371/journal.pone.0024290 Comment[SecondaryAccession] GSE27984 Comment[GEOReleaseDate] 2012-09-19 Comment[ArrayExpressSubmissionDate] 2011-03-16 Comment[GEOLastUpdateDate] 2012-09-19 Comment[AEExperimentType] transcription profiling by array SDRF File E-GEOD-27984.sdrf.txt